Literature DB >> 7827889

Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance.

R Vijeyasingam1, S J Darnton, K Jenner, C A Allen, C Billingham, H R Matthews.   

Abstract

Correlation of p53 expression with 5-year survival and histopathological parameters was examined immunohistochemically in two groups of 30 patients with oesophageal carcinoma (5-year survivors versus non-survivors). Tumour type, sex, operative procedure and age were matched. Some 64 per cent of squamous carcinomas and 79 per cent of adenocarcinomas were p53 positive. Normal squamous, normal glandular and metaplastic glandular epithelia were negative. Dysplastic squamous and glandular epithelium adjacent to tumours was positive when the tumour was positive and negative when it was not. Univariate analysis showed that nodal status (P = 0.001), and grade and depth of invasion (both P = 0.01) correlated with outcome. Correlation of tumour grade with outcome, when the most poorly differentiated area is used, is a novel finding for oesophageal carcinoma. The p53 status was not significantly associated with survival or any of these parameters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827889     DOI: 10.1002/bjs.1800811120

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Asuka Murata; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

2.  Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia.

Authors:  Aatur D Singhi; Christina A Arnold; Dora M Lam-Himlin; Marina N Nikiforova; Lysandra Voltaggio; Marcia I Canto; Kevin M McGrath; Elizabeth A Montgomery
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

3.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance.

Authors:  W G Jian; S J Darnton; K Jenner; L J Billingham; H R Matthews
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

4.  Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia.

Authors:  A P Ireland; D K Shibata; P Chandrasoma; R V Lord; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 5.  Barrett's esophagus. The significance of p53 in clinical practice.

Authors:  A P Ireland; G W Clark; T R DeMeester
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

6.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

7.  p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis.

Authors:  M Yasuda; H Kuwano; M Watanabe; Y Toh; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

8.  Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.

Authors:  M H Kulke; R D Odze; K S Thakore; G Thomas; H Wang; M Loda; C Eng
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

9.  Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.

Authors:  Lianghai Wang; Xiaodan Yu; Jing Li; Zhiyu Zhang; Jun Hou; Feng Li
Journal:  BMC Cancer       Date:  2016-07-01       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.